Board Members | Glenmark Pharma

Google Play App Store

NARNOLIA FINANCIAL ADVISORS LTD (FORMERLY MICROSEC CAPITAL LTD.); REGISTERED OFFICE ADDRESS: MARBLE ARCH, 2ND FLOOR, OFFICE 201, 236B, A J C BOSE ROAD, KOLKATA- 700020; PHONE NO.-022-6839-1234/35; WEBSITE WWW.NARNOLIA.COM. CORRESPONDENCE OFFICE: 101 & 102, 1ST FLOOR, BUILDING NO. 27, ROAD NO. 17, MIDC, MAROL, ANDHERI EAST, MUMBAI – 400093; PHONE NO.: +91 22 6839 1200; Read More

You can get in touch with us at care@narnolia.com if you have any questions. In case of any grievances, please leave us an email at: ig@narnolia.com

Filing of complaints on SEBI SCORES Website - Easy & Quick

a. Register on SEBI SCORES | b. Mandatory details for filing complaints on SCORES | Name, PAN, Address, Mobile Number, Email ID | c. Benefits: i. Effective Communication ii. Speedy redressal of the grievances

Issued in public interest by Narnolia: Prevent unauthorised transactions in your trading/demat account- Update your mobile number/email ID with your stock broker/depository participant. Receive information of your transactions/alerts directly from Exchange/Depository on your mobile/email at the end of the day. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. Investors don’t need to issue cheques while subscribing to IPOs. Just write your bank account number and sign the application form to authorise your bank to make a payment on your behalf in case of allotment. You don’t have to worry about refunds as the money remains in the investor's account.

It has been brought to the notice of SEBI by Central Economic Intelligence Bureau, Department of Revenue, GOI, that certain fraudsters are collecting data of customers who are already into trading either in NSE / BSE and send them bulk messages on the pretext of providing investment tips and luring them to invest with them in their bogus firms by promising huge profits. Hence, the investors are requested to take note of the above and exercise caution and due care.

Chairman	Glenn Saldanha
Managing Director	Glenn Saldanha
Company Secretary	Harish Kuber
Executive Director	Cherylann Pinto VS Mani
Non Executive Director	Rajesh V Desai
Promoter & Non-Executive Director	B E Saldanha
Non Executive Independent Director	Brian W Tempest Bernard Munos Sridhar Gorthi Julio F Ribeiro Milind Sarwate D R Mehta Saira Ramasastry

Narnolia

Simple & Secure Trading App with Narnolia

Company Information

GLENMARK PHARMACEUTICALS LTD.

Knowledge Center

Directory